Poop pills aim to stamp out superbugs in the gut
NCT ID NCT07106580
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether capsules containing freeze-dried stool from healthy donors can safely remove multidrug-resistant organisms (MDROs) from the intestines of 48 adults who carry these bacteria without symptoms. Participants will take either the fecal transplant capsules or a placebo over 3 days and be monitored for 6 months. The goal is to see if this approach can decolonize the gut and prevent future infections.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
lyophilized fecal microbiota transplantation (FMT) capsules
What this could lead to
If it works, this could offer a simple, pill-based way to eliminate dangerous drug-resistant bacteria from the gut, reducing infection risk.
What could go wrong
This is an early Phase 1/2 trial with only 48 participants, so results may not apply broadly. The treatment may not clear the bacteria, and side effects are still being studied.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLONIZATION, ASYMPTOMATIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Hospital Center Rijeka
RECRUITINGRijeka, 51000, Croatia
Contact Phone: •••-•••-•••• Email: •••••@•••••